Moll A C, Imhof S M, Bouter L M, Kuik D J, Den Otter W, Bezemer P D, Koten J W, Tan K E
Department of Ophthalmology, Free University, Amsterdam, The Netherlands.
Int J Cancer. 1996 Aug 7;67(4):515-9. doi: 10.1002/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V.
The aim of this register-based follow-up study was to evaluate the long-term cumulative incidence of second primary tumors (SPT) among survivors of hereditary retinoblastoma, with special interest for the incidence of pineoblastoma in retinoblastoma patients born after 1970. The Dutch Retinoblastoma Register was completed and updated: in the period 1945-1994, 639 retinoblastoma patients were registered. The vital status of each patient was obtained from the municipal registries and the Central Office of Genealogy. SPT were traced and histopathologically confirmed. Survival curves and cumulative incidence of SPT were calculated by the Kaplan-Meier method. The survival of patients with hereditary retinoblastoma was significantly shorter than that of patients with non-hereditary retinoblastoma. The cumulative incidence of SPT in hereditary patients was 3.7 and 17.7% at the ages of 10 and 35 years, respectively. Long-term follow-up revealed a high proportion of melanomas (7 melanomas out of 28 SPT). In the sub-cohort of the hereditary-retinoblastoma patient group born after 1970, the cumulative incidence of pineoblastomas at the age of 5 years was 9.3%. Our results suggest that patients with hereditary retinoblastoma should have careful follow-up, and procedures for diagnosing SPT and pineoblastomas at an early and potentially treatable stage should be developed.
这项基于登记的随访研究旨在评估遗传性视网膜母细胞瘤幸存者中第二原发性肿瘤(SPT)的长期累积发病率,特别关注1970年后出生的视网膜母细胞瘤患者中松果体母细胞瘤的发病率。荷兰视网膜母细胞瘤登记册已完成并更新:在1945年至1994年期间,登记了639例视网膜母细胞瘤患者。从市政登记处和中央家谱办公室获取了每位患者的生命状态。追踪并经组织病理学证实了SPT。采用Kaplan-Meier方法计算了SPT的生存曲线和累积发病率。遗传性视网膜母细胞瘤患者的生存期明显短于非遗传性视网膜母细胞瘤患者。遗传性患者中SPT的累积发病率在10岁和35岁时分别为3.7%和17.7%。长期随访发现黑色素瘤的比例很高(28例SPT中有7例黑色素瘤)。在1970年后出生的遗传性视网膜母细胞瘤患者亚组中,5岁时松果体母细胞瘤的累积发病率为9.3%。我们的结果表明,遗传性视网膜母细胞瘤患者应进行仔细随访,并应制定在早期且可能可治疗阶段诊断SPT和松果体母细胞瘤的程序。